Letter to the Editor
Approach to post-COVID-19 syndrome (PC19S): How long to maintain corticotherapy and heparin after discharge from intensive care?
Abordaje del síndrome post-COVID 19 (PC19S): ¿cuánto tiempo deben mantenerse la corticoterapia y la heparina tras el alta de cuidados intensivos?
José López Castro
Internal Medicine Dept. Hospital Público de Monforte, Lugo, Spain
Read
841
Timeswas read the article
309
Total PDF
532
Total HTML
Share statistics
array:23 [ "pii" => "S0211139X21000846" "issn" => "0211139X" "doi" => "10.1016/j.regg.2021.05.002" "estado" => "S300" "fechaPublicacion" => "2021-11-01" "aid" => "1228" "copyright" => "SEGG" "copyrightAnyo" => "2021" "documento" => "simple-article" "crossmark" => 1 "subdocumento" => "cor" "cita" => "Rev Esp Geriatr Gerontol. 2021;56:380" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "itemSiguiente" => array:17 [ "pii" => "S0211139X21001700" "issn" => "0211139X" "doi" => "10.1016/j.regg.2021.10.001" "estado" => "S300" "fechaPublicacion" => "2021-11-01" "aid" => "1253" "documento" => "simple-article" "crossmark" => 0 "subdocumento" => "ind" "cita" => "Rev Esp Geriatr Gerontol. 2021;56:381" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "es" => array:6 [ "idiomaDefecto" => true "titulo" => "Agradecimientos Revista Española de Geriatría y Gerontología 2021" "tienePdf" => "es" "tieneTextoCompleto" => 0 "paginas" => array:1 [ 0 => array:1 [ "paginaInicial" => "381" ] ] "contienePdf" => array:1 [ "es" => true ] ] "idiomaDefecto" => "es" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0211139X21001700?idApp=UINPBA00004N" "url" => "/0211139X/0000005600000006/v1_202110290648/S0211139X21001700/v1_202110290648/es/main.assets" ] "itemAnterior" => array:18 [ "pii" => "S0211139X21000858" "issn" => "0211139X" "doi" => "10.1016/j.regg.2021.05.003" "estado" => "S300" "fechaPublicacion" => "2021-11-01" "aid" => "1229" "copyright" => "SEGG" "documento" => "simple-article" "crossmark" => 1 "subdocumento" => "crp" "cita" => "Rev Esp Geriatr Gerontol. 2021;56:378-9" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "en" => array:11 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Clinical case</span>" "titulo" => "Atypical presentation of Tako-tsubo Syndrome in an 89-year-old patient: A case report" "tienePdf" => "en" "tieneTextoCompleto" => "en" "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "378" "paginaFinal" => "379" ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Presentación atípica de Síndrome de Tako-tsubo en paciente de 89 años: a propósito de un caso" ] ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:7 [ "identificador" => "fig0005" "etiqueta" => "Fig. 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr1.jpeg" "Alto" => 1904 "Ancho" => 2340 "Tamanyo" => 594089 ] ] "descripcion" => array:1 [ "en" => "<p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">In the echocardiogram, triangles show apical akinesia a ballooning and stars show hypercontractility in bases. The EKG shows a sinus rhythm with complete AV block and a ventricular pacemaker stimulation that causes a broad QRS and leftward QRS axis, with a concordant repolarization image in D-I.</p>" ] ] ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Itxaso Marín-Epelde, Amaya Capón-Sáez, Marina Sánchez-Latorre, Nicolás Martínez-Velilla" "autores" => array:4 [ 0 => array:2 [ "nombre" => "Itxaso" "apellidos" => "Marín-Epelde" ] 1 => array:2 [ "nombre" => "Amaya" "apellidos" => "Capón-Sáez" ] 2 => array:2 [ "nombre" => "Marina" "apellidos" => "Sánchez-Latorre" ] 3 => array:2 [ "nombre" => "Nicolás" "apellidos" => "Martínez-Velilla" ] ] ] ] ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0211139X21000858?idApp=UINPBA00004N" "url" => "/0211139X/0000005600000006/v1_202110290648/S0211139X21000858/v1_202110290648/en/main.assets" ] "en" => array:12 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Letter to the Editor</span>" "titulo" => "Approach to post-COVID-19 syndrome (PC19S): How long to maintain corticotherapy and heparin after discharge from intensive care?" "tieneTextoCompleto" => true "saludo" => "Dear Editor:" "paginas" => array:1 [ 0 => array:1 [ "paginaInicial" => "380" ] ] "autores" => array:1 [ 0 => array:3 [ "autoresLista" => "José López Castro" "autores" => array:1 [ 0 => array:3 [ "nombre" => "José" "apellidos" => "López Castro" "email" => array:1 [ 0 => "jlcastro126@hotmail.com" ] ] ] "afiliaciones" => array:1 [ 0 => array:2 [ "entidad" => "Internal Medicine Dept. Hospital Público de Monforte, Lugo, Spain" "identificador" => "aff0005" ] ] ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Abordaje del síndrome post-COVID 19 (PC19S): ¿cuánto tiempo deben mantenerse la corticoterapia y la heparina tras el alta de cuidados intensivos?" ] ] "textoCompleto" => "<span class="elsevierStyleSections"><p id="par0005" class="elsevierStylePara elsevierViewall">SARS-CoV-2 is a pro-inflammatory and prothrombogenic virus with a high mutagenic profile, which produces active infection of variable duration in various organs and systems<a class="elsevierStyleCrossRef" href="#bib0040"><span class="elsevierStyleSup">1</span></a> and it has been observed that patients who have already suffered from the disease, especially in its more severe forms such as bilateral pneumonia or respiratory distress, present symptoms and signs of chronic multiorganic involvement. Given that there is a generalised chronic reactive endotheliitis with thrombosis markers (<span class="elsevierStyleSmallCaps">d</span>-dimer, von Willebrand Factor...) elevated in patients after discharge from Intensive care and which persists for weeks or even months,<a class="elsevierStyleCrossRefs" href="#bib0045"><span class="elsevierStyleSup">2,3</span></a> the possibility of chronic immunomodulatory treatment (corticotherapy) and anticoagulant treatment (with low molecular weight heparin) has been recommended in the medium term,<a class="elsevierStyleCrossRef" href="#bib0055"><span class="elsevierStyleSup">4</span></a> without being able to specify a specific time frame but in the light of the available evidence it seems prudent for at least 6 months to 1 year, evaluating clinical response every 2 months, especially in those patients who have had a high viral load at the beginning of the disease and who have maintained it for more than 4 weeks, since particularly in these patients, similar conditions to residual pulmonary fibrosis (up to 15%), neurological sequelae and even cases of fulminant myocarditis with a severe prognosis have been described. Immunomodulatory treatment would decrease oxidative stress and fibroblast activator factor production, thus minimizing global endothelial damage and especially at lung level, having already been proven in animal models.<a class="elsevierStyleCrossRef" href="#bib0060"><span class="elsevierStyleSup">5</span></a> Although the virus has already been eliminated from the organism, it can be demonstrated by repeated negative PCR, the pro-inflammatory and prothrombotic state at the endothelial level in the microvasculature remains in some patients due to the formation of immune complexes, generating a chronic reactive endothelitis with multiple vascular affectation, preferably in the lungs (up to 60%) and central nervous system (up to 59–65%)<a class="elsevierStyleCrossRef" href="#bib0065"><span class="elsevierStyleSup">6</span></a> that ends up in the lungs in approximately 2 or 3 months in a picture that mimics a fibrotic interstitial pneumopathy clearly different from classic pulmonary fibrosis,<a class="elsevierStyleCrossRef" href="#bib0070"><span class="elsevierStyleSup">7</span></a> conditioning an autoimmune hyperexcitability of the endothelium that remains after the acute clinical course of the disease and favours a progressive decrease in pulmonary compliance. This results in an urgent need to research into whether the prolong immunomodulatory treatment (corticotherapy) and anticoagulant treatment (low molecular weight heparin) in the long term in patients who have suffered severe SARS-CoV-2 infection will improve the prognosis and decrease the sequelae of this disease.</p></span>" "pdfFichero" => "main.pdf" "tienePdf" => true "bibliografia" => array:2 [ "titulo" => "References" "seccion" => array:1 [ 0 => array:2 [ "identificador" => "bibs0015" "bibliografiaReferencia" => array:7 [ 0 => array:3 [ "identificador" => "bib0040" "etiqueta" => "1" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "F. Zhou" 1 => "T. Yu" 2 => "R. Du" 3 => "G. Fan" 4 => "Y. Liu" 5 => "Z. Liu" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/S0140-6736(20)30566-3" "Revista" => array:6 [ "tituloSerie" => "Lancet" "fecha" => "2020" "volumen" => "395" "paginaInicial" => "1054" "paginaFinal" => "1062" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/32171076" "web" => "Medline" ] ] ] ] ] ] ] ] 1 => array:3 [ "identificador" => "bib0045" "etiqueta" => "2" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Post-COVID-19 syndrome (PC-19S) and disseminated microthrombosis: the role of the von Willebrand Factor and antiphospholipid antibodies" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "C. Sieiro Santos" 1 => "J. López Castro" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.6061/clinics/2021/e2784" "Revista" => array:5 [ "tituloSerie" => "Clinics (Sao Paulo)" "fecha" => "2021" "volumen" => "76" "numero" => "March" "paginaInicial" => "e2784" ] ] ] ] ] ] 2 => array:3 [ "identificador" => "bib0050" "etiqueta" => "3" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Role of lupus anticoagulant and von Willebrand factor in chronic reactive endotheliitis in COVID-19" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "M.L. López Reboiro" 1 => "R. Suárez Fuentetaja" 2 => "R. Gutiérrez López" 3 => "B. Ares Castro-Conde" 4 => "C. Sardiña González" 5 => "I. Navarro Menéndez" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.jinf.2021.03.006" "Revista" => array:3 [ "tituloSerie" => "J Infect" "fecha" => "2021" "numero" => "March" ] ] ] ] ] ] 3 => array:3 [ "identificador" => "bib0055" "etiqueta" => "4" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Post-COVID19 syndrome (PC19S): chronic reactive endotheliitis and multiple vascular disease" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:1 [ 0 => "J. López Castro" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.20344/amp.15089" "Revista" => array:5 [ "tituloSerie" => "Acta Med Port" "fecha" => "2020" "volumen" => "33" "paginaInicial" => "855" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/33496259" "web" => "Medline" ] ] ] ] ] ] ] ] 4 => array:3 [ "identificador" => "bib0060" "etiqueta" => "5" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Stabilizing mast cells by commonly used drugs: a novel therapeutic target to relieve post-COVID syndrome?" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:1 [ 0 => "I. Kazama" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.5582/ddt.2020.03095" "Revista" => array:6 [ "tituloSerie" => "Drug Discov Ther" "fecha" => "2020" "volumen" => "14" "paginaInicial" => "259" "paginaFinal" => "261" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/33116043" "web" => "Medline" ] ] ] ] ] ] ] ] 5 => array:3 [ "identificador" => "bib0065" "etiqueta" => "6" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Cognitive impairments four months after COVID-19 hospital discharge: pattern, severity and association with illness variables" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "K.W. Miskowiak" 1 => "S. Johnsen" 2 => "S.M. Sattler" 3 => "S. Nielsen" 4 => "K. Kunalan" 5 => "J. Rungby" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.euroneuro.2021.03.019" "Revista" => array:7 [ "tituloSerie" => "Eur Neuropsychopharmacol" "fecha" => "2021" "volumen" => "46" "numero" => "March" "paginaInicial" => "39" "paginaFinal" => "48" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/33823427" "web" => "Medline" ] ] ] ] ] ] ] ] 6 => array:3 [ "identificador" => "bib0070" "etiqueta" => "7" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Pulmonary fibrosis and COVID-19: the potential role for antifibrotic therapy" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "P.M. George" 1 => "A.U. Wells" 2 => "R.G. Jenkins" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/S2213-2600(20)30225-3" "Revista" => array:3 [ "tituloSerie" => "Lancet Respir Med" "fecha" => "2020" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/24429275" "web" => "Medline" ] ] ] ] ] ] ] ] ] ] ] ] ] "idiomaDefecto" => "en" "url" => "/0211139X/0000005600000006/v1_202110290648/S0211139X21000846/v1_202110290648/en/main.assets" "Apartado" => array:4 [ "identificador" => "7718" "tipo" => "SECCION" "es" => array:2 [ "titulo" => "Cartas al Editor" "idiomaDefecto" => true ] "idiomaDefecto" => "es" ] "PDF" => "https://static.elsevier.es/multimedia/0211139X/0000005600000006/v1_202110290648/S0211139X21000846/v1_202110290648/en/main.pdf?idApp=UINPBA00004N&text.app=https://www.elsevier.es/" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0211139X21000846?idApp=UINPBA00004N" ]
| Year/Month | Html | Total | |
|---|---|---|---|
| 2024 November | 4 | 2 | 6 |
| 2024 October | 24 | 13 | 37 |
| 2024 September | 26 | 15 | 41 |
| 2024 August | 26 | 16 | 42 |
| 2024 July | 25 | 15 | 40 |
| 2024 June | 30 | 12 | 42 |
| 2024 May | 26 | 21 | 47 |
| 2024 April | 21 | 17 | 38 |
| 2024 March | 21 | 25 | 46 |
| 2024 February | 20 | 9 | 29 |
| 2024 January | 15 | 11 | 26 |
| 2023 December | 13 | 7 | 20 |
| 2023 November | 9 | 4 | 13 |
| 2023 October | 7 | 26 | 33 |
| 2023 September | 3 | 16 | 19 |
| 2023 August | 2 | 1 | 3 |
| 2023 July | 0 | 7 | 7 |
| 2023 June | 2 | 2 | 4 |
| 2023 May | 3 | 5 | 8 |
| 2023 April | 6 | 0 | 6 |
| 2023 March | 0 | 6 | 6 |
| 2023 February | 5 | 6 | 11 |
| 2023 January | 3 | 9 | 12 |
| 2022 December | 11 | 3 | 14 |
| 2022 November | 5 | 9 | 14 |
| 2022 October | 7 | 11 | 18 |
| 2022 September | 4 | 11 | 15 |
| 2022 August | 6 | 7 | 13 |
| 2022 July | 12 | 2 | 14 |
| 2022 June | 6 | 0 | 6 |
| 2022 May | 11 | 0 | 11 |
| 2022 April | 17 | 0 | 17 |
| 2022 March | 33 | 0 | 33 |
| 2022 February | 18 | 6 | 24 |
| 2022 January | 19 | 2 | 21 |
| 2021 December | 48 | 4 | 52 |
| 2021 November | 44 | 7 | 51 |
| 2021 September | 0 | 2 | 2 |
Show all
